Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no changes to study content or user-facing features described on the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:21:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.2 to v3.5.3, signaling a new version of the page. This indicates a minor patch rather than any substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:38:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated the location naming for the France region from "Nouvelle-Aquitaine"/"Bordeaux, Nouvelle-Aquitaine" to "New Aquitaine"/"Bordeaux, New Aquitaine" for this study’s sites.
    Difference
    0.1%
    Check dated 2026-04-23T14:37:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page shows an updated revision tag: Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:57.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision history updated to add Revision: v3.5.0 and remove Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T15:45:04.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:52:04.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.